# DNurse

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dnurse

- Industry: Healthcare
- Headquarters: Beijing, China
- Website: www.dnurse.com
- Total disclosed funding: $0.5M
- Latest round: Series A (Feb 11, 2015)
- Investors on record: 3

## About

Based in Beijing, DNurse is a technology company specializing in diabetes management through innovative smart devices and mobile applications, facilitating real-time patient monitoring and data management.DNurse, established in 2013, operates in Beijing, China, providing a comprehensive platform for diabetes management. The company recently transitioned to be a subsidiary of ETA International Group after acquisition in October 2021. Jason Li leads the company, having previously founded other technology ventures. DNurse has secured a total funding of CNY 3.000 mn through Angel rounds, with its latest investors including Sinocare Inc and Sinovation Ventures.DNurse offers a diabetes management platform that integrates smart medical devices, mobile applications, and intelligent management services to empower patients in self-managing their condition. Key offerings include glucose monitoring systems and insulin injection data collection, which upload data to the DNurse mobile application for real-time access by healthcare providers. Utilizing a cloud-based storage system, patient data is securely maintained, enhancing self-management capabilities among diabetes patients, particularly in urban areas of China.The company generates revenue via a direct-to-consumer model, providing subscriptions for its mobile application and services. Patients benefit from ongoing analysis, personalized guidance, and monitoring features as part of their diabetes management plan. Collaborations with healthcare providers may generate additional revenue by integrating DNurse's technology into clinical settings, typically involving monthly or annual fees for premium app functionalities alongside potential costs for smart devices.DNurse plans to enhance its product offering with new smart devices and mobile app features that are expected to launch in the upcoming year. Additionally, the company aims to expand into new markets across Southeast Asia by 2023. Recent funding of CNY 3.000 mn from the Angel round is intended to support these initiatives, bolstering product development and market entry strategies.

## Funding rounds

- Series A, Feb 11, 2015 — SAIF Partners, Sinovation Ventures
- Angel, Sep 1, 2013, $0.5M — Sinovation Ventures, Sinocare Inc

## Investors

- Sinovation Ventures (https://capitalatlas.ai/funds/sinovation-ventures) — Angel, Series A
- Sinocare Inc — Angel
- SAIF Partners (https://capitalatlas.ai/funds/saif-partners) — Series A